Related Experiment Videos
Lateralized cerebral dysfunction in schizophrenia and depression: gender and medication effects
M F Frazier1, M L Silverstein, L Fogg
1Illinois State Psychiatric Institute, Chicago 60612, USA.
Summary
Gender impacts neuropsychological performance in schizophrenia and major depressive disorder, particularly in complex cognitive tasks. Neuroleptic medication exacerbated dysfunction in schizophrenic patients.
Area of Science:
- Neuropsychology
- Psychiatry
- Cognitive Neuroscience
Background:
- Schizophrenia and major depressive disorder are associated with cognitive impairments.
- Cerebral lateralization and its role in cognitive deficits in these disorders are not fully understood.
- The influence of demographic factors like gender and medication on neuropsychological functioning requires further investigation.
Purpose of the Study:
- To examine the neuropsychological functioning in patients with schizophrenia and major depressive disorder.
- To investigate the effects of gender and medication status on cognitive performance.
- To explore the interaction between diagnosis, gender, medication, and cerebral lateralization.
Main Methods:
- Utilized the Luria-Nebraska Neuropsychological Battery lateralization scales.
- Assessed 52 patients with schizophrenia and 39 patients with major depressive disorder.
- Analyzed data considering gender, medication status, diagnosis, and laterality variables.
Main Results:
- Gender significantly influenced neuropsychological performance, especially in complex cognitive-perceptual skills, more so in depressives than schizophrenics.
- No significant gender-related left hemisphere disadvantage was found in schizophrenics.
- Neuroleptic medication in schizophrenics correlated with increased perceptual-cognitive dysfunction, while medication had no significant effect on depressives.
- Cerebral impairment levels were similar across hemispheres for both diagnostic groups.
Conclusions:
- Gender plays a role in the manifestation of cognitive deficits in schizophrenia and major depressive disorder.
- Neuroleptic medication appears to exacerbate cognitive dysfunction in schizophrenic patients.
- The findings suggest equivalent cerebral impairment across hemispheres, challenging some existing theories on lateralized deficits in these conditions.